» Articles » PMID: 25821472

Comparisons of Mouse Mesenchymal Stem Cells in Primary Adherent Culture of Compact Bone Fragments and Whole Bone Marrow

Overview
Journal Stem Cells Int
Publisher Wiley
Specialty Cell Biology
Date 2015 Mar 31
PMID 25821472
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The purification of mouse bone marrow mesenchymal stem cells (BMSCs) by using the standard method of whole bone marrow adherence to plastic still remains ineffective. An increasing number of studies have indicated compact bone as an alternative source of BMSCs. We isolated BMSCs from cultured compact bone fragments and investigated the proliferative capacity, surface immunophenotypes, and osteogenic and adipogenic differentiations of the cells after the first trypsinization. The fragment culture was based on the fact that BMSCs were assembled in compact bones. Thus, the procedure included flushing bone marrow out of bone cavity and culturing the fragments without any collagenase digestion. The cell yield from cultured fragments was slightly less than that from cultured bone marrow using the same bone quantity. However, the trypsinized cells from cultured fragments exhibited significantly higher proliferation and were accompanied with more CD90 and CD44 expressions and less CD45 expression. The osteogenic and adipogenic differentiation capacity of cells from cultured fragments were better than those of cells from bone marrow. The directly adherent culture of compact bone is suitable for mouse BMSC isolation, and more BMSCs with potentially improved proliferation capacity can be obtained in the primary culture.

Citing Articles

Research Progress on Cardiac Tissue Construction of Mesenchymal Stem Cells for Myocardial Infarction.

Yang G, Ma D, Ma C, Bai Y Curr Stem Cell Res Ther. 2023; 19(7):942-958.

PMID: 37612870 DOI: 10.2174/1574888X18666230823091017.


Uncarboxylated osteocalcin promotes osteogenesis and inhibits adipogenesis of mouse bone marrow-derived mesenchymal stem cells via the PKA-AMPK-SIRT1 axis.

Gao L, Gong F, Ma L, Yang J Exp Ther Med. 2021; 22(2):880.

PMID: 34194558 PMC: 8237271. DOI: 10.3892/etm.2021.10312.


Effect of TNF-α and IL-6 on Compact Bone-Derived Cells.

Zhang Y, Li X, Chihara T, Dong H, Kagami H Tissue Eng Regen Med. 2021; 18(3):441-451.

PMID: 33847914 PMC: 8169734. DOI: 10.1007/s13770-021-00336-1.


Isolation and characterization of mesenchymal stem cells in orthopaedics and the emergence of compact bone mesenchymal stem cells as a promising surgical adjunct.

Anastasio A, Gergues M, Lebhar M, Rameshwar P, Fernandez-Moure J World J Stem Cells. 2020; 12(11):1341-1353.

PMID: 33312402 PMC: 7705465. DOI: 10.4252/wjsc.v12.i11.1341.


Naringin and bone marrow mesenchymal stem cells repair articular cartilage defects in rabbit knees through the transforming growth factor-β superfamily signaling pathway.

Ye C, Chen J, Qu Y, Liu H, Yan J, Lu Y Exp Ther Med. 2020; 20(5):59.

PMID: 32952649 PMC: 7485297. DOI: 10.3892/etm.2020.9187.


References
1.
Reinders M, De Fijter J, Roelofs H, Bajema I, de Vries D, Schaapherder A . Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med. 2013; 2(2):107-11. PMC: 3659754. DOI: 10.5966/sctm.2012-0114. View

2.
Short B, Brouard N, Simmons P . Prospective isolation of mesenchymal stem cells from mouse compact bone. Methods Mol Biol. 2008; 482:259-68. DOI: 10.1007/978-1-59745-060-7_16. View

3.
Ranganath S, Levy O, Inamdar M, Karp J . Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell. 2012; 10(3):244-58. PMC: 3294273. DOI: 10.1016/j.stem.2012.02.005. View

4.
FRIEDENSTEIN A, Chailakhjan R, LALYKINA K . The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970; 3(4):393-403. DOI: 10.1111/j.1365-2184.1970.tb00347.x. View

5.
Williams A, Hatzistergos K, Addicott B, McCall F, Carvalho D, Suncion V . Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation. 2012; 127(2):213-23. PMC: 3579523. DOI: 10.1161/CIRCULATIONAHA.112.131110. View